2013
DOI: 10.1016/j.bbcan.2013.08.002
|View full text |Cite
|
Sign up to set email alerts
|

CXCR3, a double-edged sword in tumor progression and angiogenesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
134
2

Year Published

2015
2015
2019
2019

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 107 publications
(142 citation statements)
references
References 82 publications
6
134
2
Order By: Relevance
“…4). 13,24 CXCL9 and CXCL10, the two most upregulated genes in our analysis, both have important pro-tumor roles [114][115][116][117] and can both be activated by the transcription factor NF-kb, as suggested in our model (Fig. 4).…”
Section: Cross-talk Between Transcription Factors Cytokines and Aqpssupporting
confidence: 60%
“…4). 13,24 CXCL9 and CXCL10, the two most upregulated genes in our analysis, both have important pro-tumor roles [114][115][116][117] and can both be activated by the transcription factor NF-kb, as suggested in our model (Fig. 4).…”
Section: Cross-talk Between Transcription Factors Cytokines and Aqpssupporting
confidence: 60%
“…In addition, EGFR (also known as ERBB1) and ERBB3, found in these lesions, are part of the ErbB family, which has been shown to be critical for Schwann cell differentiation and survival (52). Genes involved in cell death included TNFSF10 (also know as TRAIL), CXCR3, CCL19, and IDO, which regulate apoptosis (53)(54)(55)(56), consistent with the prominent apoptosis present in RR lesions in comparison to nonreactional patients (57,58). We previously demonstrated that M. leprae ligands induce apoptosis of Schwann cells through TLR2, providing one mechanism by which activation of the innate immune response contributes to nerve injury in leprosy (59).…”
Section: Discussionmentioning
confidence: 99%
“…Paired analysis of mRNAs and proteins in tissue and serum might provide evidence to resolve this discrepancy. As CXCL11 has distinct immunoregulatory functions, in contrast to immunostimulatory functions mediated by CXCL9 and CXCL10 (24,25), we prefer the following nonmutually exclusive explanations of how CXCL11, even in the presence of CXCL9 and CXCL10, may limit T-cell effector function as a part of negative feedback loop: (i) disrupting chemokine gradients for directional migration of T cells (26), (ii) preventing CXCR3-CXCL9/10 interaction by promoting receptor internalization (24), (iii) suppressing T-cell responses through induction and/or recruitment of regulatory T cells (25,27), and (iv) promoting growth and metastasis of tumors expressing CXCR3 (28)(29)(30)(31).…”
Section: Discussionmentioning
confidence: 99%